Physician profile
Priti Ranjan
NPI 1356579247
$1,251.48
in general payments reported to CMS, 2019-2025
21 companies · $196 in 2025
The $196 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $91.31 · 2020: $259 · 2021: $267 · 2022: $79.65 · 2023: $199 · 2024: $160 · 2025: $196.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $555.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $554.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $217.91 | 2020-2025 | Farxiga, Breztri, Airsupra |
| Lilly USA, LLC | $173.86 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Merck Sharp & Dohme LLC | $125.30 | 2019-2021 | |
| Exact Sciences Corporation | $113.34 | 2023-2025 | Cologuard Collection Kit |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $99.91 | 2021 | |
| Pfizer INC. | $92.44 | 2023-2025 | |
| Abbott Laboratories | $85.03 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $49.96 | 2023-2024 | |
| Medtronic, INC. | $35.76 | 2022-2024 | Intellis Adaptivestim |
| Si-Bone, INC. | $31.65 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $29.44 | 2020 | |
| Amarin Pharma, INC. | $29.44 | 2021 | |
| Amgen INC. | $28.50 | 2025 | Krystexxa |
| Ultragenyx Pharmaceutical INC. | $24.65 | 2022 | |
| Genentech USA, INC. | $21.59 | 2020 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $19.68 | 2025 | Veozah |
| Novo Nordisk INC | $15.95 | 2025 | Ozempic |
| Renalytix Ai, INC. | $15.12 | 2023 | Kidneyintelx Blood Collection Convenience Kit |
| Allergan, INC. | $14.30 | 2019 | |
| Linus Health, INC. | $13.94 | 2023 | |
| Glaxosmithkline, LLC. | $13.71 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Priti Ranjan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.